Skip to main content
Journal cover image

Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory.

Publication ,  Journal Article
Chamberlain, AM; Cooper-DeHoff, RM; Fontil, V; Nilles, EK; Shaw, KM; Smith, M; Lin, F; Vittinghoff, E; Maeztu, C; Todd, JV; Carton, T; Liu, M ...
Published in: Mayo Clin Proc
May 2023

OBJECTIVE: To explore trends in blood pressure (BP) control before and during the COVID-19 pandemic. PATIENTS AND METHODS: Health systems participating in the National Patient-Centered Clinical Research Network (PCORnet) Blood Pressure Control Laboratory Surveillance System responded to data queries, producing 9 BP control metrics. Averages of the BP control metrics (weighted by numbers of observations in each health system) were calculated and compared between two 1-year measurement periods (January 1, 2019, through December 31, 2019, and January 1, 2020, through December 31, 2020). RESULTS: Among 1,770,547 hypertensive persons in 2019, BP control to <140/<90 mm Hg varied across 24 health systems (range, 46%-74%). Reduced BP control occurred in most health systems with onset of the COVID-19 pandemic; the weighted average BP control was 60.5% in 2019 and 53.3% in 2020. Reductions were also evident for BP control to <130/<80 mm Hg (29.9% in 2019 and 25.4% in 2020) and improvement in BP (reduction of 10 mm Hg in systolic BP or achievement of systolic BP <140 mm Hg; 29.7% in 2019 and 23.8% in 2020). Two BP control process metrics exhibited pandemic-associated disruption: repeat visit in 4 weeks after a visit with uncontrolled hypertension (36.7% in 2019 and 31.7% in 2020) and prescription of fixed-dose combination medications among those with 2 or more drug classes (24.6% in 2019 and 21.5% in 2020). CONCLUSION: BP control decreased substantially during the COVID-19 pandemic, with a corresponding reduction in follow-up health care visits among persons with uncontrolled hypertension. It is unclear whether the observed decline in BP control during the pandemic will contribute to future cardiovascular events.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Mayo Clin Proc

DOI

EISSN

1942-5546

Publication Date

May 2023

Volume

98

Issue

5

Start / End Page

662 / 675

Location

England

Related Subject Headings

  • Pandemics
  • Hypertension
  • Humans
  • COVID-19
  • Blood Pressure
  • Antihypertensive Agents
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chamberlain, A. M., Cooper-DeHoff, R. M., Fontil, V., Nilles, E. K., Shaw, K. M., Smith, M., … Pletcher, M. J. (2023). Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory. Mayo Clin Proc, 98(5), 662–675. https://doi.org/10.1016/j.mayocp.2022.12.024
Chamberlain, Alanna M., Rhonda M. Cooper-DeHoff, Valy Fontil, Ester Kim Nilles, Kathryn M. Shaw, Myra Smith, Feng Lin, et al. “Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory.Mayo Clin Proc 98, no. 5 (May 2023): 662–75. https://doi.org/10.1016/j.mayocp.2022.12.024.
Chamberlain AM, Cooper-DeHoff RM, Fontil V, Nilles EK, Shaw KM, Smith M, et al. Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory. Mayo Clin Proc. 2023 May;98(5):662–75.
Chamberlain, Alanna M., et al. “Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory.Mayo Clin Proc, vol. 98, no. 5, May 2023, pp. 662–75. Pubmed, doi:10.1016/j.mayocp.2022.12.024.
Chamberlain AM, Cooper-DeHoff RM, Fontil V, Nilles EK, Shaw KM, Smith M, Lin F, Vittinghoff E, Maeztu C, Todd JV, Carton T, O’Brien EC, Faulkner Modrow M, Wozniak G, Rakotz M, Sanchez E, Smith SM, Polonsky TS, Ahmad FS, Liu M, McClay JC, VanWormer JJ, Taylor BW, Chrischilles EA, Wu S, Viera AJ, Ford DE, Hwang W, Knowlton KU, Pletcher MJ. Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory. Mayo Clin Proc. 2023 May;98(5):662–675.
Journal cover image

Published In

Mayo Clin Proc

DOI

EISSN

1942-5546

Publication Date

May 2023

Volume

98

Issue

5

Start / End Page

662 / 675

Location

England

Related Subject Headings

  • Pandemics
  • Hypertension
  • Humans
  • COVID-19
  • Blood Pressure
  • Antihypertensive Agents
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences